Free beta access. 5 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

Gene therapy checks the impact of chemical weapons

Peter H. Schwartz, April 2020, Indiana University Center for Bioethics, Indiana University School of Medicinehttps://www.cell.com/molecular-therapy-family/molecular-therapy/pdf/S1525-0016(20)30142-8.pdf, " Ethics of Gene Therapy in the Military: Promise and Potential Problems" Molecular Therapy Vol. 28 No 4 (ermo/sms, Acc:6-8-2022)

Recent research on mice has shown that gene therapy can neutralize the effect of certain types of chemical weapons.1,2 This approach may one day protect people, but it also raises worries. Some of these questions stem from it being gene therapy, but most stem from the fact that its key use would be on the battlefield. The most challenging questions involve assessing a therapy that is designed to protect soldiers but could also hurt them.

It’s important to begin the discussion by reviewing how dangerous chemical weapons are and why they have been banned by international treaty since the 1960s.3,4 The most commonly used nerve agents, such as sarin, tabun, and VX, are organophosphates that inhibit acetylcholinesterase and lead to nerve dysfunction, resulting in the inability to breathe, heart problems, seizures, and death. Chemoprotective clothing and gas masks provide some defense, but they are not perfect. Once a person is exposed, medical treatments have limited efficacy and may not be able to forestall death or brain damage.3,4

If an attack is expected, then some medications can be given to reduce or block the effect of nerve agents, though these treatments have limitations too. One approach being tested in animals is to inject an enzyme that quickly breaks down organophosphates.1,2 But these enzymes do not last in the bloodstream very long, so they may need to be given right before a possible attack, perhaps multiple times. The gene therapy approach may solve this problem: scientists injected a gene into mice that was taken up by their liver cells and made the protective enzyme. The study found that the enzyme remained active in the blood for the entire 5-month study and allowed the mice to survive multiple injections of the nerve agents.1,2

The experiment is just“proof of concept,” of course, since much more research would be needed to make the treatment for humans and identify its risks and benefits. But the potential advantages are clear. Despite the international treaty banning their use, chemical warfare is still being used, most recently in Syria.

The approach will attract the attention of ethicists in part because it is a possible gene therapy. Of note, though, the approach does not have two features that often raise the most concern about genetics. First, the treatment is somatic therapy, not heritable, so it doesn’t involve changes in the germline or affect the next generation.5 Second, it is an intervention countering a physical danger, and thus does not fall in the realm of “enhancement” of the sort that many worry gene therapy will eventually aim at, attempting to make people (or soldiers) smarter, taller, or stronger.6,7

Sign in to recut, update, or save this card.